Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KEURIG DR PEPPER INC.

(KDP)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/24/2021 11/26/2021 11/29/2021 11/30/2021 12/01/2021 Date
35.62(c) 34.98(c) 35.17(c) 33.99(c) 33.56 Last
3 885 854 2 846 541 3 977 529 5 796 114 4 991 575 Volume
-0.81% -1.80% +0.54% -3.36% -1.27% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 12 589 M - -
Net income 2021 1 918 M - -
Net Debt 2021 11 986 M - -
P/E ratio 2021 24,9x
Yield 2021 2,08%
Sales 2022 13 127 M - -
Net income 2022 2 276 M - -
Net Debt 2022 11 081 M - -
P/E ratio 2022 21,0x
Yield 2022 2,26%
Capitalization 48 197 M 48 197 M -
EV / Sales 2021 4,78x
EV / Sales 2022 4,52x
Nbr of Employees 27 000
Free-Float 59,8%
More Financials
Company
Keurig Dr Pepper Inc. is North American n░ 3 nonalcoholic drinks producer. The group markets soft drinks, flavoured water, fruit juices, concentrated and syrups especially under the brands Dr Pepper, Snapple, 7 UP, Schweppes, Mott's, A&W, Sunkist, Hawaiian Punch, Canada Dry, RC Cola, Diet Rite, Clamato, Orangina and Yoo-Hoo. At the end of 2019, the group had 24 production sites located especially in the United... 
More about the company
Ratings of Keurig Dr Pepper Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about KEURIG DR PEPPER INC.
11/17Keurig and Disney+ Spread Holiday Cheer with "Home Sweet Home Alone" Viewing Party
PR
11/01Barclays Adjusts Price Target on Keurig Dr Pepper to $41 from $39, Keeps Overweight Rat..
MT
10/29UBS Lifts Price Target on Keurig Dr Pepper to $42 From $41, Reiterates Buy Rating
MT
10/29Barclays Adjusts Price Target on Keurig Dr Pepper to $41 From $39, Maintains Overweight..
MT
10/28KEURIG DR PEPPER INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
10/28Keurig Dr Pepper Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
10/28Keurig Dr Pepper Lifts Full-Year Sales Outlook on Higher Third-Quarter Results Despite ..
MT
10/28Keurig Dr Pepper Q3 Adjusted Earnings, Net Sales Rise; Updates Full-Year Outlook
MT
10/28Keurig Dr Pepper Reports Strong Q3 2021 Results and Raises Net Sales Guidance for the Y..
PU
10/28Earnings Flash (KDP) KEURIG DR PEPPER Posts Q3 Revenue $3.25B, vs. Street Est of $3.159..
MT
10/28Earnings Flash (KDP) KEURIG DR PEPPER Posts Q3 EPS $0.44, vs. Street Est of $0.44
MT
10/28Keurig Dr Pepper Inc. Raises Net Sales Guidance for the Year 2021
CI
10/05KEURIG DR PEPPER : to Report Third Quarter 2021 Results and Host Conference Call
PR
10/04KEURIG DR PEPPER : Barclays Adjusts Keurig Dr Pepper PT to $38 From $42, Maintains Overwei..
MT
10/04KEURIG DR PEPPER : Jefferies & Co Adjusts Keurig Dr Pepper PT to $41 From $43, Maintains B..
MT
More news
News in other languages on KEURIG DR PEPPER INC.
10/28Keurig Dr Pepper relève ses prévisions de ventes pour l'ensemble de l'année grâce à l'a..
10/28Les valeurs à suivre aujourd'hui à Wall Street - Jeudi 28 octobre 2021
10/28KEURIG DR. PEPPER : les ventes battent les attentes
10/28KEURIG DR PEPPER : hausse du bénéfice ajusté et des ventes nettes au troisième trimestre e..
10/28Earnings Flash (KDP) KEURIG DR PEPPER affiche un chiffre d'affaires de 3,25 milliards d..
More news
Analyst Recommendations on KEURIG DR PEPPER INC.
More recommendations
Chart KEURIG DR PEPPER INC.
Duration : Period :
Keurig Dr Pepper Inc. Technical Analysis Chart | KDP | US49271V1008 | MarketScreener
Technical analysis trends KEURIG DR PEPPER INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 33,56 $
Average target price 38,86 $
Spread / Average Target 15,8%
EPS Revisions
Managers and Directors
Robert James Gamgort Executive Chairman, President & CEO
Ozan Dokmecioglu Chief Financial Officer
David J. Thomas Chief Research & Development Officer
Genevieve Hovde Independent Director
Paul S. Michaels Independent Director
Sector and Competitors